Team

Pushing the boundaries in everything we do.

We’re driven by the idea that medicines of the future will be generated, not discovered.

Founded in 2018 by Flagship Pioneering, Generate Biomedicines is the latest in a long line of unprecedented multi-product platform companies like Moderna Therapeutics, Rubius Therapeutics, Indigo Agriculture, and Sana Biotechnology. These companies have pioneered breakthroughs in a variety of life sciences fields. Our leadership team has a track record of successfully pursuing new ideas and are committed to the extraordinary mission of generative medicines.

Leadership

  • Michael Nally

    CEO
    Generate Biomedicines
    CEO-Partner
    Flagship Pioneering
  • Molly Gibson

    Co-Founder & Chief Strategy and Innovation Officer
    Generate Biomedicines
    Principal
    Flagship Pioneering
  • Mike Nohaile

    Chief Scientific Officer
    Generate Biomedicines
  • Gevorg Grigoryan

    Co-Founder & Chief Technology Officer
    Generate Biomedicines
  • Kristen Hopson

    Vice President, Preclinical Discovery and Development
    Generate Biomedicines
  • Adam Root

    Vice President of Protein Sciences
    Generate Biomedicines
  • Andy Beam

    Head of Machine Learning
    Generate Biomedicines
  • Jake Feala

    Head of Computational Biology
    Generate Biomedicines
  • Stephen Kottmann

    Head of Informatics
    Generate Biomedicines

Board of Directors

  • Noubar Afeyan

    Chair of the Board
    Generate Biomedicines
    Co-Founder and CEO
    Flagship Pioneering
  • Geoffrey von Maltzahn

    Co-Founder & Director
    Generate Biomedicines
    General Partner
    Flagship Pioneering
  • Frances Arnold

    Director
    Generate Biomedicines
    Nobel Laureate, Professor
    California Institute for Technology
  • Stéphane Bancel

    Director
    Generate Biomedicines
    CEO
    Moderna
  • Gary Pisano

    Director
    Generate Biomedicines
    Harry Figgie Professor of Business Administration
    Harvard Business School